Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | SFRP1 | Q8N474 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | WNT3 | P56703 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | IKBKB | O14920 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4784754 | 0.84 | MAPT (0.48) | KMT2AMEN1HTR6TSHRSMN1; SMN2 | |
| SCHEMBL4782529 | 0.84 | SFRP1 (0.56) | SFRP1HTR6WNT3 | |
| SCHEMBL4780921 | 0.84 | SFRP1 (0.48) | SFRP1HTR6WNT3 | |
| Hydrochloric Acid SCHEMBL4781661 | 0.83 | SFRP1 (0.55) | SFRP1HTR6WNT3 | |
| SCHEMBL4784394 | 0.82 | HTR6 (0.50) | SFRP1HTR6WNT3 | |
| SCHEMBL4784256 | 0.82 | SFRP1 (0.46) | SFRP1HTR6WNT3 | |
| SCHEMBL4781473 | 0.82 | SFRP1 (0.46) | SFRP1HTR6WNT3 | |
| SCHEMBL4783391 | 0.82 | SFRP1 (0.46) | SFRP1HTR6WNT3 | |
| SCHEMBL4783287 | 0.82 | HTR6 (0.47) | SFRP1HTR6WNT3 | |
| SCHEMBL4783281 | 0.82 | HTR6 (0.47) | SFRP1HTR6WNT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008060998-A1 | INDOLE SULFONAMIDES AS SFRP-1 MODULATORS | WYETH (US) | 2008-05-22 | — | — | WO | disclosed |